Skip to main content

Table 1

From: Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T

 

Age (years)

LVEDV (ml)

IVSD (mm)

EF (%)

T1 (ms)

T2 (ms)

Group 1 (n=10)

51,80 ± 28,28

134,55 ± 42,42

9,11 ± 0,71

58,78 ± 7,07

1009,30 ± 13,44 (p <0,05)

54 ± 1,41

Group 2 (n=6)

54,33 ± 5,66

117 ± 21,92

9,20 ± 1,06

60,8 ± 18,38

988 ± 10,61

54,17 ± 2,12

Group 3 (n=8)

55,13 ± 11,31

110,57 ± 16,26

9,69 ± 0,71

66,50 ± 1,41

1001,86 ± 0,71

54,50 ± 2,08

Group 4 (n=20)

50,60 ± 31,82

150,40 ± 61,52

9,96 ± 0,71

62,55 ± 4,24

957,65 ± 15,56

52,95 ± 4,95

  1. Patient characteristics as well as T1 and T2 relaxation times.